Technology News and Research

RSS

Isis, Genzyme submit European MAA for mipomersen to treat familial hypercholesterolemia

Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc. today announced that Genzyme has submitted a marketing authorization application (MAA) to the European Medicines Agency seeking approval for the 200 mg weekly dose of mipomersen for the treatment of homozygous and severe heterozygous familial hypercholesterolemia.

28 Jul 2011

Deciding what to eat can be influenced by shifting attention towards healthy side of life

You're trying to decide what to eat for dinner. Should it be the chicken and broccoli? The super-sized fast-food burger? Skip it entirely and just get some Rocky Road?

28 Jul 2011

FDA makes regulatory process for previously cleared 510(k) medical devices less challenging

The U.S. Food and Drug Administration today issued draft guidance that clarifies when changes or modifications to a previously cleared 510(k) device require a new premarket submission.

28 Jul 2011

University of Pittsburgh to honor Synthetic Genomics CEO with Dickson Prize

The scientist-entrepreneur who led efforts to map the first draft of the human genome as well as the complete diploid genome and to construct the first synthetic bacterium has been named this year's recipient of the University of Pittsburgh's Dickson Prize in Medicine.

28 Jul 2011

Dilemma of single vs. double embryo transfers

Elsevier announced the publication of several commentaries in the scientific journal Reproductive BioMedicine Online on the subject of how many embryos it is safe and proper to place in a uterus, and how best to regulate this decision. It is a dilemma faced by all patients anxiously caught between no pregnancies at all or facing the prospect of twins or triplets. In this difficult place it is often all too easy to think that the latter option must be the best. But is it?

28 Jul 2011

U.S. should address sex-selective abortions

The contentious nature of abortion in American politics is "distracting U.S. policymakers from what should be the real conversation in a country that leads the world in human reproductive technology: whether to allow parents to use a growing range of methods to select for characteristics like sex (or diseases that come on late in life and, perhaps one day, IQ) in their children.

28 Jul 2011

Insect virus holds key to safer stem cell therapy: Singapore scientists

The future of regenerative medicine lies in harnessing the potential of the human body to renew and repair itself. Now, scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a new genetic engineering technique that promises safer stem cell therapy for cancer patients. Using an insect virus, the team of researchers successfully inserted a therapeutic gene into a safe site in the DNA of human embryonic stem cells without compromising the functionality of the engineered cells.

28 Jul 2011

BD to acquire Carmel Pharma

BD, a leading global medical technology company, announced today that it signed a definitive agreement to acquire Carmel Pharma, Inc., a Swedish company that manufactures the PhaSeal System, the leading closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials.

From BD (Becton, Dickinson and Company) 28 Jul 2011

Viewpoints: Chambliss on reviving Gang of Six proposal; WSJ on Medicare Part D; Friedman on 'doing this right'

I joined five other senators to identify the difficult issues and make the hard, necessary decisions to address the twin challenges of our deficit and debt. ... Among other provisions, our proposal reduces the debt by $3.7 trillion over the next 10 years, stabilizes our publicly held debt by 2014, and imposes tough and honest budget enforcement.

28 Jul 2011

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced results of operations for the second quarter of 2011.

27 Jul 2011

Epitomics launches 23 novel cancer-related antibodies

Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal technology, today announced the Company has now launched 23 novel cancer-related antibodies that were developed through a partnership with the National Cancer Institute's Center for Cancer Research.

27 Jul 2011

Dow second quarter sales increase to $16.0 billion

Dow reported earnings of $0.84 per share. This compares with reported earnings of $0.50 per share in the same period last year.

27 Jul 2011

Teleflex second quarter net revenues increase 9.2% to $391.3 million

Teleflex Incorporated today announced financial results for the second quarter and six months ended June 26, 2011.

27 Jul 2011

TMS rolls out MUNI for law enforcement and other government agencies

Total Medical Solutions (TMS), specializing in complex care for workers' compensation, has rolled out MUNI for municipalities, law enforcement and other government agencies.

27 Jul 2011

Underwater-treadmill improves mobility following spinal-cord injury

The result of research often is shown in hard and fast metrics. For Janette Rodgers, the only metric she cares about is that her wheelchair, once her prison day in and day out, now sits empty 90 percent of the time— in large part because of the hours she spent in 270 gallons of water.

27 Jul 2011

Study reveals several compounds that block cancer cell invasion

Metastasis-the spread of cancer from the place where it first started to another place in the body-is the most common reason that cancer treatments fail. To metastasize, some types of cancer cells rely on invadopodia, cellular membrane projections that act like feet, helping them "walk" away from the primary tumor and invade surrounding tissues.

27 Jul 2011

Technology News and Research

Isis, Genzyme submit European MAA for mipomersen to treat familial hypercholesterolemia

Deciding what to eat can be influenced by shifting attention towards healthy side of life

FDA makes regulatory process for previously cleared 510(k) medical devices less challenging

University of Pittsburgh to honor Synthetic Genomics CEO with Dickson Prize

Dilemma of single vs. double embryo transfers

U.S. should address sex-selective abortions

Insect virus holds key to safer stem cell therapy: Singapore scientists

BD to acquire Carmel Pharma

Viewpoints: Chambliss on reviving Gang of Six proposal; WSJ on Medicare Part D; Friedman on 'doing this right'

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Epitomics launches 23 novel cancer-related antibodies

Dow second quarter sales increase to $16.0 billion

Teleflex second quarter net revenues increase 9.2% to $391.3 million

TMS rolls out MUNI for law enforcement and other government agencies

Underwater-treadmill improves mobility following spinal-cord injury

Study reveals several compounds that block cancer cell invasion

Positive results from phase Ib/IIa trial of novel molecular technique for Duchenne muscular dystrophy

UBC research projects receive CIHR grants to promote greater equity in global health

New convenient device can track degenerative eye disease

New silicone chip could make genetic analysis far more sensitive, rapid, and cost-effective

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News